A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Rα Chain With Immune Activating and Tumoricidal Effects In Vivo
Open Access
- 1 July 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (7) , 1293-1301
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosisEuropean Journal of Haematology, 2009
- Local IL-21 Promotes the Therapeutic Activity of Effector T cells by Decreasing Regulatory T Cells Within the Tumor MicroenvironmentMolecular Therapy, 2009
- Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer TherapyCancer Research, 2008
- IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitroBlood, 2008
- IL-21–mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytesBlood, 2008
- IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complexBlood, 2006
- The IL-21 receptor augments Th2 effector function and alternative macrophage activationJournal of Clinical Investigation, 2006
- Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitroEuropean Journal of Immunology, 2005
- Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 2002